TD Waterhouse Canada’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.9M Buy
35,498
+33,710
+1,885% +$8.4M 0.02% 311
2025
Q4
$431K Buy
1,788
+425
+31% +$109K ﹤0.01% 723
2025
Q3
$368K Buy
1,363
+22
+2% +$6.01K ﹤0.01% 751
2025
Q2
$344K Sell
1,341
-40
-3% -$9.54K ﹤0.01% 726
2025
Q1
$307K Buy
1,381
+227
+20% +$53K ﹤0.01% 728
2024
Q4
$264K Buy
1,154
+34
+3% +$8.19K ﹤0.01% 747
2024
Q3
$267K Buy
1,120
+1
+0.1% +$223 ﹤0.01% 726
2024
Q2
$209K Buy
1,119
+374
+50% +$75.9K ﹤0.01% 759
2024
Q1
$139K Buy
745
+295
+66% +$54.1K ﹤0.01% 841
2023
Q4
$75.4K Buy
+450
New +$69.1K ﹤0.01% 866
2022
Q3
Sell
-105
Closed -$29.2K 1771
2022
Q2
$29.2K Buy
+105
New +$22.4K ﹤0.01% 1025

Other funds holding RMD

TD Waterhouse Canada's RMD Position: Q1 2026 in Review

TD Waterhouse Canada increased its ResMed (RMD) stake by 1,885% in Q1 2026, buying an estimated $8.4M and bringing the position to 35,498 shares worth $7.9M. The position accounts for 0.02% of the portfolio, ranked #311.

TD Waterhouse Canada first reported a position in RMD in Q2 2022 and has held it in 11 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • TD Waterhouse Canada held 35,498 shares of ResMed worth $7.9M as of Q1 2026.
  • TD Waterhouse Canada bought 33,710 ResMed shares in Q1 2026, an estimated $8.4M.
  • ResMed made up 0.02% of TD Waterhouse Canada's portfolio in Q1 2026, its #311 holding.
  • TD Waterhouse Canada first reported a position in ResMed in Q2 2022 and has held it in 11 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.